Decitabine 50 MG Injection — RxCUI 636631
RxNorm drug concept · Semantic clinical drug
RxCUI 636631
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
22 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI636631
Official nameDecitabine 50 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped22
Package NDCs mapped22
Reported Medicaid activity (SDUD)3,012 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Decitabine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Decitabine targets myelodysplastic syndromes, or MDS — conditions where your bone marrow isn't producing enough healthy blood cells and instead makes abnormal ones. It works by hel...
- What exactly is decitabine treating in my body?
- Decitabine is given as an IV infusion at a clinic or infusion center — you won't be taking anything by mouth at home. Depending on which schedule your doctor chose, you'll either c...
- How will I receive this medication, and how long will treatment last?
🕸️ Concept Web — How Decitabine 50 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Decitabine 50 MG Injection
RxCUI 636631 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Decitabine
15657IN
-
Decitabine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Dacogen
636242BN
-
Dacogen
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Decitabine Injection
1806907SCDF -
Decitabine Injectable Product
1157195SCDG -
Decitabine Injection [Dacogen]
1806910SBDF -
Dacogen Injectable Product
1166941SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Decitabine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Decitabine 50 MG
1806906SCDC -
Decitabine 50 MG Injection [Dacogen]
644989SBD -
Decitabine 50 MG [Dacogen]
1806909SBDC
-
Decitabine 50 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Decitabine 50 MG
SCDC · 1806906 -
Decitabine Injection
SCDF · 1806907 -
Decitabine Injectable Product
SCDG · 1157195
Brand-Name Concepts
-
Decitabine 50 MG Injection [Dacogen]
SBD · 644989 -
Decitabine 50 MG [Dacogen]
SBDC · 1806909 -
Decitabine Injection [Dacogen]
SBDF · 1806910 -
Dacogen Injectable Product
SBDG · 1166941 -
Dacogen
BN · 636242
📦 FDA Products & Package NDCs
22 products · 22 package NDCs
22 package NDCs map to RxCUI 636631 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9385-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9385-01) / 1 INJECTIO... | decitabine | Hikma Pharmaceuticals USA Inc. | 2022-04-15 |
| 16729-0224-05 | 1 VIAL in 1 CARTON (16729-224-05) / 20 mL in 1 VIAL | Decitabine | Accord Healthcare Inc. | 2017-03-08 |
| 25021-0219-20 | 1 VIAL in 1 CARTON (25021-219-20) / 20 mL in 1 VIAL | Decitabine | Sagent Pharmaceuticals | 2023-11-01 |
| 31722-0304-31 | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-304-31) / 10 mL in 1... | Decitabine | Camber Pharmaceuticals, Inc. | 2024-05-10 |
| 43598-0427-37 | 1 VIAL, SINGLE-USE in 1 CARTON (43598-427-37) / 10 mL in 1... | Decitabine | Dr. Reddy's Laboratories Inc. | 2014-12-05 |
| 47335-0361-41 | 1 KIT in 1 CARTON (47335-361-41) * 10 mL in 1 VIAL, SINGLE... | decitabine | Sun Pharmaceutical Industries, Inc. | 2014-01-24 |
| 55111-0556-10 | 1 VIAL, SINGLE-USE in 1 CARTON (55111-556-10) / 10 mL in 1... | Decitabine | Dr.Reddy's Laboratories Limited | 2013-07-11 |
| 55150-0376-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-376-01) / 26 mL in 1... | Decitabine | Eugia US LLC | 2021-09-20 |
| 67184-0535-01 | 1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL | Decitabine | Qilu Pharmaceutical Co., Ltd. | 2021-04-12 |
| 67457-0316-25 | 1 VIAL in 1 CARTON (67457-316-25) / 20 mL in 1 VIAL | Decitabine | Mylan Institutional LLC | 2018-10-10 |
| 68001-0573-41 | 1 VIAL in 1 CARTON (68001-573-41) / 1 INJECTION, POWDER, LY... | DECITABINE | BluePoint Laboratories | 2023-05-23 |
| 68001-0618-37 | 1 VIAL in 1 CARTON (68001-618-37) / 20 mL in 1 VIAL | Decitabine | BluePoint Laboratories | 2024-05-03 |
| 68001-0642-41 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-642-41) / 10 mL in 1... | Decitabine | BluePoint Laboratories | 2025-05-01 |
| 68083-0528-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-528-01) / 10 mL in 1... | decitabine | Gland Pharma Limited | 2020-11-23 |
| 70121-1644-01 | 1 VIAL, SINGLE-USE in 1 CARTON (70121-1644-1) / 20 mL in 1... | Decitabine | Amneal Pharmaceuticals LLC | 2019-12-01 |
| 71288-0119-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-119-20) / 20 mL in 1... | Decitabine | Meitheal Pharmaceuticals Inc. | 2021-07-02 |
| 71288-0119-91 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-119-91) / 20 mL in 1... | Decitabine | Meitheal Pharmaceuticals Inc. | 2021-07-02 |
| 72162-2634-02 | 1 VIAL, SINGLE-USE in 1 CARTON (72162-2634-2) / 20 mL in 1... | Decitabine | Bryant Ranch Prepack | 2026-05-06 |
| 72205-0031-01 | 1 VIAL, SINGLE-USE in 1 CARTON (72205-031-01) / 20 mL in 1... | Decitabine | Novadoz Pharmaceuticals LLC | 2019-08-28 |
| 72205-0036-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72205-036-01) / 10 mL in 1... | Decitabine | Novadoz Pharmaceuticals LLC | 2020-03-02 |
| 72603-0107-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-107-01) / 10 mL in 1... | Decitabine | Northstar Rx LLC | 2020-08-17 |
| 75834-0190-01 | 1 VIAL in 1 CARTON (75834-190-01) / 20 mL in 1 VIAL | DECITABINE | Nivagen Pharmaceuticals, Inc. | 2020-12-17 |
Observed labelers:
BluePoint Laboratories (3) ·
Meitheal Pharmaceuticals Inc. (2) ·
Novadoz Pharmaceuticals LLC (2) ·
Accord Healthcare Inc. (1) ·
Amneal Pharmaceuticals LLC (1) ·
Bryant Ranch Prepack (1)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0894 | Decitabine injection | 15 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.